117 related articles for article (PubMed ID: 24968791)
1. Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma.
Ohashi R; Matsuda Y; Ishiwata T; Naito Z
Oncol Rep; 2014 Sep; 32(3):1163-9. PubMed ID: 24968791
[TBL] [Abstract][Full Text] [Related]
2. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
3. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
[TBL] [Abstract][Full Text] [Related]
7. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
8. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.
Yamada SM; Yamada S; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K
Neurol Res; 2002 Apr; 24(3):244-8. PubMed ID: 11958417
[TBL] [Abstract][Full Text] [Related]
11. Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells.
Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):626-639. PubMed ID: 28930565
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
Matsuda Y; Yoshimura H; Suzuki T; Uchida E; Naito Z; Ishiwata T
Cancer Sci; 2014 Sep; 105(9):1212-9. PubMed ID: 24975163
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
Plate KH; Breier G; Farrell CL; Risau W
Lab Invest; 1992 Oct; 67(4):529-34. PubMed ID: 1434531
[TBL] [Abstract][Full Text] [Related]
16. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
Li S; Yang B; Li G; He S; Li Y
Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]